We are live on ! Find out more
AFMD

Affimed

Delisted

AFMD was delisted on the 19th of May, 2025.

34 hedge funds and large institutions have $42.9M invested in Affimed in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $22.5M → $42.9M (+$20.4M)

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

6% more funds holding

Funds holding: 3234 (+2)

0.55% more ownership

Funds ownership: 3.76%4.31% (+0.55%)

23% less call options, than puts

Call options by funds: $90K | Put options by funds: $117K

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
34
Holders Change
+2
Holders Change %
+6.25%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
8
Reduced
11
Closed
8
Calls
$90K
Puts
$117K
Net Calls
-$27K
Net Calls Change
+$61K

AFMD Hedge Fund Activity: Q1 2017 in Review

34 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Affimed (AFMD) for Q1 2017, worth a combined $42.9M — up 91% from $22.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AFMD positions and 8 closed out — a net gain of 2 holders — while 8 added to existing stakes and 11 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $8.55M. The largest seller was OrbiMed, cutting an estimated $2.98M.

  • 34 institutional investors held Affimed (AFMD) as of Q1 2017, up from 32 in Q4 2016.
  • Funds reported $42.9M of Affimed stock for Q1 2017, up 91% quarter-over-quarter.
  • 10 funds opened new Affimed positions in Q1 2017 and 8 closed out, a net change of +2 holders.
  • The largest Affimed buyer in Q1 2017 was NEA Management Company, an estimated $8.55M added.
  • The largest Affimed seller in Q1 2017 was OrbiMed, an estimated $2.98M sold.

Based on aggregated 13F filings for Q1 2017.